Latest Insider Transactions at Cor Medix Inc. (CRMD)
This section provides a real-time view of insider transactions for Cor Medix Inc. (CRMD). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CorMedix Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CorMedix Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 17
2025
|
Robert A Stewart Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+40.98%
|
-
|
|
Jan 17
2025
|
Alan W Dunton Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+38.31%
|
-
|
|
Jan 17
2025
|
Joseph Todisco Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
23,977
-4.84%
|
$287,724
$12.17 P/Share
|
|
Jan 17
2025
|
Joseph Todisco Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
187,500
+27.45%
|
-
|
|
Jan 17
2025
|
Steven W Lefkowitz Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+19.92%
|
-
|
|
Jan 17
2025
|
Myron Kaplan Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+12.44%
|
-
|
|
Jan 17
2025
|
Janet Dillione Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+24.16%
|
-
|
|
Jan 17
2025
|
Gregory Scott Duncan Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+50.0%
|
-
|
|
Jan 10
2025
|
Erin Mistry EVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,689
-5.33%
|
$62,579
$11.19 P/Share
|
|
Jan 10
2025
|
Joseph Todisco Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
17,829
-5.47%
|
$196,119
$11.19 P/Share
|
|
Jan 10
2025
|
Matthew T David Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,515
-6.4%
|
$71,665
$11.19 P/Share
|
|
Jan 10
2025
|
Elizabeth Masson Hurlburt EVP |
SELL
Payment of exercise price or tax liability
|
Direct |
5,790
-4.76%
|
$63,690
$11.19 P/Share
|
|
Jan 02
2025
|
Kaufman Beth Zelnick Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,844
-9.01%
|
$94,752
$8.22 P/Share
|
|
Jan 02
2025
|
Kaufman Beth Zelnick Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
87,500
+39.96%
|
-
|
|
Jan 02
2025
|
Matthew T David Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,648
-7.83%
|
$69,184
$8.22 P/Share
|
|
Jan 02
2025
|
Matthew T David Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
62,500
+36.14%
|
-
|
|
Jan 02
2025
|
Elizabeth Masson Hurlburt EVP |
SELL
Payment of exercise price or tax liability
|
Direct |
11,378
-8.56%
|
$91,024
$8.22 P/Share
|
|
Jan 02
2025
|
Elizabeth Masson Hurlburt EVP |
BUY
Grant, award, or other acquisition
|
Direct |
87,500
+39.7%
|
-
|
|
Jan 02
2025
|
Erin Mistry EVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,830
-6.84%
|
$62,640
$8.22 P/Share
|
|
Jan 02
2025
|
Erin Mistry EVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
62,500
+35.31%
|
-
|
|
Dec 12
2024
|
Kaufman Beth Zelnick Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,044
-9.67%
|
$48,352
$8.77 P/Share
|
|
Dec 12
2024
|
Kaufman Beth Zelnick Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+16.67%
|
-
|
|
Nov 14
2024
|
Elizabeth Masson Hurlburt EVP |
SELL
Open market or private sale
|
Direct |
140,027
-75.52%
|
$1,540,297
$11.18 P/Share
|
|
Nov 14
2024
|
Elizabeth Masson Hurlburt EVP |
BUY
Exercise of conversion of derivative security
|
Direct |
140,027
+15.45%
|
$560,108
$4.56 P/Share
|
|
Oct 31
2024
|
Erin Mistry EVP, Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
1,500
+2.8%
|
$13,500
$9.99 P/Share
|
|
May 10
2024
|
Joseph Todisco Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
26,982
-7.65%
|
$134,910
$5.17 P/Share
|
|
Mar 13
2024
|
Joseph Todisco Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
13,561
+3.7%
|
$40,683
$3.74 P/Share
|
|
Jan 12
2024
|
Erin Mistry EVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,389
-7.99%
|
$13,167
$3.47 P/Share
|
|
Jan 12
2024
|
Erin Mistry EVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+47.66%
|
-
|
|
Jan 12
2024
|
Matthew T David Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,216
-9.81%
|
$15,648
$3.47 P/Share
|
|
Jan 12
2024
|
Matthew T David Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+48.47%
|
-
|
|
Jan 12
2024
|
Elizabeth Masson Hurlburt EVP |
SELL
Payment of exercise price or tax liability
|
Direct |
4,603
-7.94%
|
$13,809
$3.47 P/Share
|
|
Jan 12
2024
|
Elizabeth Masson Hurlburt EVP |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+46.3%
|
-
|
|
Jan 12
2024
|
Joseph Todisco Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
13,781
-3.9%
|
$41,343
$3.47 P/Share
|
|
Jan 12
2024
|
Joseph Todisco Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
133,333
+27.41%
|
-
|
|
Dec 15
2023
|
Alan W Dunton Director |
BUY
Open market or private purchase
|
Direct |
3,000
+16.44%
|
$9,000
$3.3 P/Share
|
|
Dec 14
2023
|
Alan W Dunton Director |
BUY
Open market or private purchase
|
Direct |
3,000
+19.67%
|
$9,000
$3.45 P/Share
|
|
Dec 12
2023
|
Kaufman Beth Zelnick Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+50.0%
|
-
|
|
Nov 17
2023
|
Erin Mistry EVP, Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+16.95%
|
$4,000
$4.0 P/Share
|
|
Nov 16
2023
|
Steven W Lefkowitz Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+16.58%
|
$30,000
$2.25 P/Share
|
|
Sep 08
2023
|
Joseph Todisco Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+4.35%
|
$30,000
$3.71 P/Share
|
|
May 18
2023
|
Myron Kaplan Director |
BUY
Open market or private purchase
|
Direct |
6,000
+3.49%
|
$24,000
$4.54 P/Share
|
|
May 17
2023
|
Paulo F Costa |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+50.0%
|
$40,000
$4.65 P/Share
|
|
May 17
2023
|
Alan W Dunton Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+24.49%
|
$12,000
$4.33 P/Share
|
|
May 17
2023
|
Joseph Todisco Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+2.33%
|
$20,000
$4.58 P/Share
|
|
May 17
2023
|
Robert A Stewart Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+47.62%
|
$40,000
$4.37 P/Share
|
|
May 10
2023
|
Joseph Todisco Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
37,443
-15.46%
|
$187,215
$5.3 P/Share
|
|
Nov 15
2022
|
Joseph Todisco Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
20,000
+7.63%
|
$60,000
$3.82 P/Share
|
|
Aug 24
2022
|
Joseph Todisco Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
4,700
+2.07%
|
$14,100
$3.92 P/Share
|
|
May 17
2022
|
Myron Kaplan Director |
BUY
Open market or private purchase
|
Direct |
5,000
+3.03%
|
$15,000
$3.78 P/Share
|